Latest AI and machine learning research in dementia for healthcare professionals.
Alzheimer's disease (AD) causes amyloid formation, neuritic dystrophy, gliosis, synapse loss, behavioral abnormalities, and weight loss. 5xFAD transgenic mice simulate these alterations. To further investigate overall tau reduction as a therapeutic strategy for AD-related abnormalities, we compared 5xFAD mice carrying 2, 1, or 0 Mapt alleles encoding endogenous wildtype tau. Behavioral alterations...
Access to holistic, multimodal data improves the performance of Artificial Intelligence (AI) in medical classification tasks compared to utilizing single modalities or data sources. However, the inherent heterogeneity and complexity of clinical real-world data pose significant challenges to structured data analysis and AI application. This heterogeneity includes missing values, multiple time point...
Causal discovery recovers directed structure from observational data and is increasingly used in clinical settings to support mechanism reasoning and ...
Care robots are increasingly being introduced into healthcare settings, raising important questions about their acceptance and ethical implementation....
Identifying reliable Alzheimer's disease (AD) markers typically requires manual, labor-intensive transcription and expert analysis, limiting its scale...
As populations age, cognitive decline from mild cognitive impairment (MCI) to dementia is a defining health challenge of the coming decades, yet routi...
The promise of multimodal fusion lies in combining complementary sources of evidence, yet more evidence does not always yield a better prediction. Rec...
EEG-based machine learning shows promise for neurodegenerative disease classification, but robustness to sample imbalance, center heterogeneity, and v...
Background: Dementia caregiving carries substantial emotional and psychological consequences, but most evidence comes from structured surveys and inte...
Accurate identification of Alzheimers disease (AD) using resting-state functional magnetic resonance imaging (rs-fMRI) remains challenging due to the ...
Activities of daily living (ADLs) provide important indicators of functional decline in people living with dementia, motivating the need for continuou...
Acoustic biomarkers show promise for detecting Alzheimer's Disease (AD), yet whether the cues driving diagnostic AI align with those salient to human ...
Pretrained EEG foundation models are increasingly proposed for clinical decoding, but their transfer across populations and robustness to negative con...
INTRODUCTION: Cognitive syndrome diagnosis (Normal, Mild Cognitive Impairment (MCI), Dementia) is important for summarizing disease status and predict...
INTRODUCTION: The biomarker-based amyloid/ tau/ neurodegeneration (A/T/N) framework has become a popular staging method for Alzheimer's disease (AD) r...
Introduction: Cerebral amyloid angiopathy (CAA) is characterized by amyloid-beta deposition in cortical and leptomeningeal vessels and associated with...
Scaling laws describe how model performance improves as the amount of training data increases, and recent theories such as the zeta law suggest that s...
People with Down syndrome have higher age-specific mortality rates compared to the general population as well as peers with other intellectual and dev...
Deep learning classifiers applied to structural MRI (sMRI) have achieved high performance in detecting Alzheimer's Disease (AD), yet systematic invest...
Background. Predicting conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is central to trial enrichment and care planning, y...